U.S. Machinery Stock News

Miracle-Gro, a brand under Scotts Miracle-Gro (NYSE:SMG), has launched a refreshed lineup of indoor soils and plant foods. The company has introduced new plant care solutions and its first organic plant food, tailored to indoor gardeners. The products are positioned to support easier indoor gardening and promote wellness during the winter months. For Scotts Miracle-Gro, best known for lawn and garden products, expanding its indoor range fits with growing interest in home based hobbies and...

Marriott International FY 2025 earnings snapshot Marriott International (MAR) has wrapped up FY 2025 with fourth quarter revenue of US$6.7b, basic EPS of US$1.66 and net income of US$445m, while trailing 12 month revenue stands at US$26.2b, basic EPS at US$9.53 and net income at US$2.6b. The company has seen quarterly revenue move from US$1.7b in Q4 2024 to US$6.7b in Q4 2025, with basic EPS shifting from US$1.63 to US$1.66 over the same period, and trailing 12 month revenue and EPS also...

Proficient Auto Logistics (PAL) has just posted its FY 2025 numbers, with Q4 revenue of US$105.4 million, a basic EPS loss of US$0.92, and trailing twelve month revenue of US$430.4 million against a basic EPS loss of US$1.21, alongside reported year over year revenue growth of 78.7%. The company has seen quarterly revenue move from US$91.5 million in Q3 2024 to US$93.4 million in Q4 2024, then to US$95.2 million in Q1 2025, US$115.5 million in Q2 2025, US$114.3 million in Q3 2025 and US$105.4...

If you are wondering whether National Bank Holdings is currently priced fairly or if there might be value on the table, you are in the right place. The stock last closed at US$41.83, with returns of 1.2% over 7 days, 4.4% over 30 days, 10.4% year to date, 11.0% over 3 years and 32.0% over 5 years, while the 1 year return sits at a 2.0% decline. Recent attention on the bank has focused on its share price performance over different time frames and how that lines up with the broader banking...

Arch Capital Group (ACGL) closed out FY 2025 with fourth quarter revenue of US$4.9b and basic EPS of US$3.42, alongside net income of US$1.2b. This contributed to trailing twelve month revenue of US$19.9b and EPS of US$11.83. Over recent quarters, revenue has moved from US$4.5b in Q4 2024 to US$5.1b in Q3 2025, before landing at US$4.9b in Q4 2025. Quarterly EPS shifted from US$2.48 to US$3.63 and then to US$3.42. All of this comes against a backdrop of an 82.8% trailing combined ratio, which...

Saia (SAIA) just wrapped up FY 2025 with fourth quarter revenue of US$790.0 million and basic EPS of US$1.78, alongside trailing twelve month revenue of about US$3.2 billion and EPS of US$9.54 that frame the latest print within a fuller year of operations. Over the past six quarters, revenue has ranged from US$787.6 million to US$842.1 million, while quarterly EPS has moved between US$1.78 and US$3.47. This gives a clear view of how top line and per share earnings have tracked through recent...

Recently, commentary on JOYY Inc. highlighted that the company runs profitable livestreaming and advertising platforms and holds a sizeable net cash reserve, giving it considerable flexibility for shareholder returns or reinvestment. The discussion underscored a perceived gap between JOYY’s strong financial footing and its current valuation, with regulatory concerns in China weighing on how the market values the business. Next, we’ll examine how JOYY’s strong net cash position and perceived...

Cincinnati Financial (CINF) just wrapped up FY 2025 with fourth quarter revenue of US$3.1b and basic EPS of US$4.34, alongside net income of US$676m and a reported combined ratio of 85.2%. The company has seen quarterly revenue move from US$2.5b in Q4 2024 to US$3.1b in Q4 2025, while basic EPS shifted from US$2.59 to US$4.34 over the same stretch, set against trailing twelve month EPS of US$15.32 on revenue of US$12.6b and a combined ratio of 94.9%. For investors, that mix of solid top line,...

InMode FY 2025 earnings recap and what the market narrative might be missing InMode (INMD) just wrapped up FY 2025 with Q4 revenue of US$103.9 million and basic EPS of US$0.43, setting the tone for a year where trailing twelve month revenue landed at US$370.5 million and EPS came in at US$1.45. Over recent quarters, the company has seen revenue move from US$77.9 million in Q1 2025 to US$103.9 million in Q4, while quarterly EPS ranged between US$0.26 and US$0.43, and trailing net profit margin...

Aramark (ARMK) opened fiscal Q1 2026 with revenue of US$4.8b and basic EPS of US$0.37, alongside net income excluding extra items of US$96.2m, providing a snapshot of how its food and facilities services operations are currently performing. The company reported quarterly revenue of US$4.6b in Q3 2025, US$5.0b in Q4 2025, and US$4.8b in Q1 2026, while basic EPS moved from US$0.27 to US$0.33 to US$0.37 over the same period. This sequence gives investors a clearer view of earnings power in the...

On January 30, 2026, Church & Dwight reported fourth-quarter 2025 results showing higher sales of US$1,644.2 million but lower quarterly earnings, issued 2026 guidance calling for a small reported sales decline tied to 2025 business exits alongside higher full-year EPS, raised its quarterly dividend to US$0.3075 per share, detailed a broad slate of 2026 product launches across key brands, and confirmed completion of a US$771.12 million share repurchase program. Together, the guidance for EPS...

WESCO International (WCC) just closed out FY 2025 with fourth quarter revenue of US$6.1b and basic EPS of US$3.34, supported by net income of US$165.2m. The company has seen quarterly revenue move from US$5.5b and EPS of US$3.03 in Q4 2024 to US$6.1b and EPS of US$3.34 in Q4 2025, while trailing twelve month EPS for Q4 2025 sits at US$13.05 on revenue of US$23.5b. For investors, the headline results put the focus squarely on how WESCO is converting that top line into earnings as margins and...

IRADIMED (IRMD) has just wrapped up FY 2025 with fourth quarter revenue of US$22.7 million and basic EPS of US$0.51, alongside net income of US$6.4 million, capped by trailing 12 month revenue of US$83.8 million and basic EPS of US$1.77 backed by net income of US$22.5 million. Over recent quarters the company has seen quarterly revenue move from US$19.4 million in Q4 2024 to US$22.7 million in Q4 2025, with basic EPS shifting from US$0.41 to US$0.51 over the same period. Trailing 12 month...

AMETEK (NYSE:AME) reported record fourth quarter and full year 2025 results. The company highlighted strong cash generation, solid sales and order growth, and contributions from recent acquisitions. Management pointed to continued momentum and a healthy backlog as key support factors for the business. For investors watching NYSE:AME, the latest update comes with the stock around $233.11 and multi year returns that have been strong, including 26.6% over the past year and 98.7% over five...

EVI Industries (EVI) has reported Q2 2026 revenue of US$115.3 million and basic EPS of US$0.16, alongside trailing 12 month revenue of US$427.1 million and EPS of US$0.49 that frame the latest quarter within a broader earnings picture. The company has seen quarterly revenue move from US$92.7 million in Q2 2025 to US$115.3 million in Q2 2026, with basic EPS over the same quarters shifting from US$0.08 to US$0.16 as trailing net profit margins eased from 1.8% to 1.5%. This sets up a results...

Jumia Technologies FY 2025 Earnings Snapshot Jumia Technologies (NYSE:JMIA) closed FY 2025 with fourth quarter revenue of US$61.4 million and a net income loss of US$10.3 million, while trailing twelve month revenue stood at US$188.9 million against a trailing loss of US$61.6 million. Over the last year, the company has seen quarterly revenue move from US$36.3 million in Q1 2025 to US$61.4 million in Q4, with trailing twelve month losses narrowing from US$99.1 million at the end of 2024 to...

Xylem (XYL) closed out FY 2025 with Q4 revenue of US$2.4b and basic EPS of US$1.37, on net income of US$335m, while trailing 12 month revenue stood at US$9.0b with basic EPS of US$3.93 supported by US$957m of net income. The company has seen revenue move from US$8.6b and basic EPS of US$3.67 on net income of US$890m in the prior trailing period to the latest US$9.0b and US$3.93 on US$957m. This sets up a story where investors are likely to focus on how steady margin progression and earnings...

Datadog (DDOG) has wrapped up FY 2025 with fourth quarter revenue of US$953.2 million and basic EPS of US$0.13, alongside net income of US$46.6 million. This puts a clear spotlight on how its topline and per share earnings are tracking as the year closes out. Over the past six quarters, revenue has moved from US$690.0 million in Q3 2024 to US$953.2 million in Q4 2025. Over the same period, quarterly basic EPS has ranged from US$0.15 in Q3 2024 to US$0.01 in Q2 2025 and then to US$0.13 in the...

Friedman Industries Q3 2026 Earnings Snapshot Friedman Industries (FRD) has reported Q3 2026 results with total revenue of US$168.0 million, net income of US$3.0 million and basic EPS of US$0.43, setting the tone for another data heavy quarter for investors to assess. The company has seen quarterly revenue move from US$106.8 million in Q2 2025 to US$94.1 million in Q3 2025, then to US$129.2 million in Q4 2025, US$134.8 million in Q1 2026, US$152.4 million in Q2 2026 and US$168.0 million in Q3...

Arrowhead Pharmaceuticals (NasdaqGS:ARWR) has been added to the S&P 400 index and its related sector indices. At the same time, the company has been removed from the S&P 600 index, shifting its classification within the S&P family. This index change reflects a reclassification of Arrowhead's market standing and may affect how index funds and ETFs hold the stock. Arrowhead Pharmaceuticals focuses on RNA interference based therapies, an area that has attracted steady attention as drug...

Goodyear Tire & Rubber (GT) has wrapped up FY 2025 with fourth quarter revenue of US$4.9 billion and basic EPS of US$0.36, alongside net income excluding extra items of US$105 million. This sets a clear marker after a volatile year for earnings. Over the past six quarters, revenue has moved in a relatively tight band between US$4.3 billion and just under US$5.0 billion. Quarterly basic EPS has swung from a loss of US$7.62 in Q3 2025 to positive readings in Q1, Q2 and Q4, giving you a mixed...

Masco (MAS) closed out FY 2025 with fourth quarter revenue of US$1.8 billion and basic EPS of US$0.81, alongside net income of US$165 million, setting the tone for how the full year’s performance lands with investors. Over the past four quarters, the company has seen revenue move from US$7.8 billion on a trailing basis in Q4 2024 to US$7.6 billion in Q4 2025, while trailing EPS shifted from US$3.77 to US$3.88. This provides a clear view of how the top and bottom lines have been tracking...

Enanta Pharmaceuticals Q1 2026 Earnings Snapshot Enanta Pharmaceuticals (ENTA) opened its 2026 financial year with Q1 revenue of US$18.6 million and a basic EPS loss of US$0.42, alongside a net income loss of US$11.9 million, setting a clear tone for where the business is today. The company has seen quarterly revenue fluctuate in a tight band between US$14.6 million and US$18.6 million over the last six reported periods, while basic EPS losses have ranged from about US$0.42 to US$1.36. This...

Pharvaris recently announced that six abstracts featuring its lead candidate deucrictibant for hereditary angioedema, including first-time pivotal Phase 3 RAPIDe-3 data and final Phase 2 CHAPTER-1 results, were accepted for poster presentation at the 2026 American Academy of Allergy, Asthma & Immunology Annual Meeting. This wave of data disclosures, spanning on-demand treatment, prophylaxis, and an extended-release tablet formulation, concentrates investor attention on Pharvaris’s effort to...